Objective:

To promote the adoption of interventional treatments for dry eye disease (DED) in clinical practice, emphasizing their potential to improve patient outcomes.

Approach:

Key Findings:

• Interventional treatments reduce patient compliance burdens associated with topical therapies, leading to better outcomes.
• Lacrimal occlusion with hyaluronic acid gel provides immediate symptomatic relief and improves compliance, making it a preferred first-line treatment.
• TARGET therapy shows superior outcomes compared to traditional therapies in clinical studies, enhancing patient satisfaction.

Interpretation:

Adopting an interventional approach to DED can enhance patient outcomes, streamline practice operations, and improve overall treatment efficacy, making it essential for modern ophthalmic practices.

Limitations:

• Not all treatments may be suitable for every patient, necessitating careful assessment.
• Implementation requires training and restructuring of practice workflows, which may pose initial challenges.

Conclusion:

Transitioning to an interventional treatment model for DED can significantly benefit both patients and ophthalmic practices, making it a timely and necessary shift.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.